Rockwell Medical Secures Major Deal to Supply Dialysis Products for At-Home and Acute Care
Rockwell Medical Secures Major Deal to Supply Dialysis Products for At-Home and Acute Care
Rockwell Medical, Inc. (the "Company") (NASDAQ:RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced a product purchase agreement with the leading at-home and acute care dialysis provider in the United States (the "Customer"). Under the terms of the agreement, Rockwell Medical will supply the Customer with the Company's liquid acid RenalPure and liquid bicarbonate SteriLyte, both of which will be packaged in either the Company's four-per-case packaging for larger dialysis settings or two-per-case packaging for smaller acute care and at-home care settings.
Rockwell Medical, Inc.（「公司」）（納斯達克股票代碼：RMTI）是一家爲全球透析提供商開發、製造、商業化和分銷血液透析產品組合的醫療保健公司，今天宣佈與美國領先的家庭和急性護理透析提供商（「客戶」）簽訂產品購買協議。根據協議條款，Rockwell Medical將向客戶提供公司的液體酸RenalPure和液體碳酸氫鹽Sterilyte，兩者都將採用公司針對較大型透析環境的每箱四包包裝或針對較小的急性護理和家庭護理環境的每箱兩包包裝。